Division of Pulmonary and Critical Care, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland.
Division of Thoracic Surgery, Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland.
Ann Thorac Surg. 2018 Sep;106(3):e111-e113. doi: 10.1016/j.athoracsur.2018.03.023. Epub 2018 Apr 13.
Postsurgical empyema with bronchopleural fistula can be difficult to manage. We present a patient with postoperative empyema with bronchopleural fistula who was successfully treated nonoperatively by placing an intrabronchial valve to address the bronchopleural fistula, which allowed for safe administration of intrapleural fibrinolytics and antibiotics for definitive treatment of the empyema. Although the presence of a bronchopleural fistula is considered a contraindication to the administration of intrapleural tissue plasminogen activator and deoxyribonuclease, this case demonstrates a novel use of the intrabronchial valve that allowed these medications to be used.
术后脓胸伴支气管胸膜瘘的治疗较为困难。我们报告了一例术后脓胸伴支气管胸膜瘘患者,通过放置支气管内单向活瓣成功地进行了非手术治疗,以解决支气管胸膜瘘问题,从而可以安全地给予胸腔内纤维蛋白溶解酶和抗生素,以对脓胸进行确定性治疗。尽管支气管胸膜瘘的存在被认为是胸腔内组织纤溶酶原激活物和脱氧核糖核酸酶给药的禁忌证,但本病例展示了支气管内单向活瓣的新用途,使这些药物得以应用。